98%
921
2 minutes
20
This study developed an end-to-end deep learning (DL) model using non-enhanced MRI to diagnose benign and malignant pelvic and sacral tumors (PSTs). Retrospective data from 835 patients across four hospitals were employed to train, validate, and test the models. Six diagnostic models with varied input sources were compared. Performance (AUC, accuracy/ACC) and reading times of three radiologists were compared. The proposed Model SEG-CL-NC achieved AUC/ACC of 0.823/0.776 (Internal Test Set 1) and 0.836/0.781 (Internal Test Set 2). In External Dataset Centers 2, 3, and 4, its ACC was 0.714, 0.740, and 0.756, comparable to contrast-enhanced models and radiologists (P > 0.05), while its diagnosis time was significantly shorter than radiologists (P < 0.01). Our results suggested that the proposed Model SEG-CL-NC could achieve comparable performance to contrast-enhanced models and radiologists in diagnosing benign and malignant PSTs, offering an accurate, efficient, and cost-effective tool for clinical practice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356837 | PMC |
http://dx.doi.org/10.1038/s41698-025-01077-3 | DOI Listing |
Comput Methods Programs Biomed
August 2025
CardioVascular Systems Imaging and Artificial Intelligence Lab, National Heart Centre Singapore, Singapore; Duke-NUS Medical School, Singapore; Department of Biomedical Engineering, National University of Singapore, Singapore. Electronic address:
Background And Objective: To develop an end-to-end artificial intelligence solution-video-based Multi-Point Tracking Network (MPTN), for detecting and tracking atrioventricular junction (AVJ) points from cardiovascular magnetic resonance and deriving AVJ motion parameters.
Methods: The MPTN model consists of two modules: AVJ point detection and AVJ motion tracking. The detection module utilizes convolutional-based feature extraction and elastic regression to detect all candidate AVJ points.
J Am Coll Cardiol
August 2025
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Cardiology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, California, USA. Electronic address:
Background: Accurate measurement of echocardiographic parameters is crucial for the diagnosis of cardiovascular disease and tracking of change over time; however, manual assessment requires time-consuming effort and can be imprecise. Artificial intelligence has the potential to reduce clinician burden by automating the time-intensive task of comprehensive measurement of echocardiographic parameters.
Objectives: The purpose of this study was to develop and validate open-sourced deep learning semantic segmentation models for the automated measurement of 18 anatomic and Doppler measurements in echocardiography.
Eur J Radiol
September 2025
Department of Radiology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, China. Electronic address:
Background: Homogeneous AI assessment is required for CT-T staging of gastric cancer.
Purpose: To construct an End-to-End CT-based Deep Learning (DL) model for tumor T-staging in advanced gastric cancer.
Materials And Methods: A retrospective study was conducted on 460 cases of presurgical CT patients with advanced gastric cancer between 2011 and 2024.
Int Urol Nephrol
September 2025
Portsmouth Hospitals, University NHS Trust, Portsmouth, UK.
Prostate cancer (PCa) remains one of the most prevalent cancers among men, with over 1.4 million new cases and 375,304 deaths reported globally in 2020. Current diagnostic approaches, such as prostate-specific antigen (PSA) testing and trans-rectal ultrasound (TRUS)-guided biopsies, are often Limited by low specificity and accuracy.
View Article and Find Full Text PDFObjective: Effective deep brain stimulation (DBS) treatment for Parkinson's disease requires careful adjustment of stimulation parameters and targeting to avoid motor side effects caused by activation of the internal capsule. Currently, patients must self-report side effects during device programming and implantation surgery - a challenging and subjective process that could lead to suboptimal therapy or exacerbate the time needed to optimize treatment. Motor evoked potentials (mEP), the use of electromyography to record DBS-induced muscle activation, offer a promising biomarker for objective motor side effect detection.
View Article and Find Full Text PDF